
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
Caroline S. Fox, Sherita Hill Golden, Cheryl A.M. Anderson, et al.
Diabetes Care (2015) Vol. 38, Iss. 9, pp. 1777-1803
Open Access | Times Cited: 454
Caroline S. Fox, Sherita Hill Golden, Cheryl A.M. Anderson, et al.
Diabetes Care (2015) Vol. 38, Iss. 9, pp. 1777-1803
Open Access | Times Cited: 454
Showing 1-25 of 454 citing articles:
Type 2 diabetes
Sudesna Chatterjee, Kamlesh Khunti, Melanie J. Davies
The Lancet (2017) Vol. 389, Iss. 10085, pp. 2239-2251
Closed Access | Times Cited: 2086
Sudesna Chatterjee, Kamlesh Khunti, Melanie J. Davies
The Lancet (2017) Vol. 389, Iss. 10085, pp. 2239-2251
Closed Access | Times Cited: 2086
Global vascular guidelines on the management of chronic limb-threatening ischemia
Michael S. Conte, Andrew W. Bradbury, Philippe Kolh, et al.
Journal of Vascular Surgery (2019) Vol. 69, Iss. 6, pp. 3S-125S.e40
Open Access | Times Cited: 1469
Michael S. Conte, Andrew W. Bradbury, Philippe Kolh, et al.
Journal of Vascular Surgery (2019) Vol. 69, Iss. 6, pp. 3S-125S.e40
Open Access | Times Cited: 1469
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
Michael S. Conte, Andrew W. Bradbury, Philippe Kolh, et al.
European Journal of Vascular and Endovascular Surgery (2019) Vol. 58, Iss. 1, pp. S1-S109.e33
Open Access | Times Cited: 1138
Michael S. Conte, Andrew W. Bradbury, Philippe Kolh, et al.
European Journal of Vascular and Endovascular Surgery (2019) Vol. 58, Iss. 1, pp. S1-S109.e33
Open Access | Times Cited: 1138
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
Makoto Kinoshita, Koutaro Yokote, Hidenori Arai, et al.
Journal of Atherosclerosis and Thrombosis (2018) Vol. 25, Iss. 9, pp. 846-984
Open Access | Times Cited: 695
Makoto Kinoshita, Koutaro Yokote, Hidenori Arai, et al.
Journal of Atherosclerosis and Thrombosis (2018) Vol. 25, Iss. 9, pp. 846-984
Open Access | Times Cited: 695
Diabetes and Hypertension: A Position Statement by the American Diabetes Association
Ian H. de Boer, Sripal Bangalore, Athanase Bénétos, et al.
Diabetes Care (2017) Vol. 40, Iss. 9, pp. 1273-1284
Open Access | Times Cited: 629
Ian H. de Boer, Sripal Bangalore, Athanase Bénétos, et al.
Diabetes Care (2017) Vol. 40, Iss. 9, pp. 1273-1284
Open Access | Times Cited: 629
5. Lifestyle Management:Standards of Medical Care in Diabetes—2019
Diabetes Care (2018) Vol. 42, Iss. Supplement_1, pp. S46-S60
Closed Access | Times Cited: 624
Diabetes Care (2018) Vol. 42, Iss. Supplement_1, pp. S46-S60
Closed Access | Times Cited: 624
4. Lifestyle Management:Standards of Medical Care in Diabetes—2018
Diabetes Care (2017) Vol. 41, Iss. Supplement_1, pp. S38-S50
Open Access | Times Cited: 524
Diabetes Care (2017) Vol. 41, Iss. Supplement_1, pp. S38-S50
Open Access | Times Cited: 524
Diabetic emergencies — ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Guillermo E. Umpierrez, Mary T. Korytkowski
Nature Reviews Endocrinology (2016) Vol. 12, Iss. 4, pp. 222-232
Closed Access | Times Cited: 450
Guillermo E. Umpierrez, Mary T. Korytkowski
Nature Reviews Endocrinology (2016) Vol. 12, Iss. 4, pp. 222-232
Closed Access | Times Cited: 450
Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
Deborah Hinnen
Diabetes Spectrum (2017) Vol. 30, Iss. 3, pp. 202-210
Open Access | Times Cited: 313
Deborah Hinnen
Diabetes Spectrum (2017) Vol. 30, Iss. 3, pp. 202-210
Open Access | Times Cited: 313
5. Facilitating Behavior Change and Well-being to Improve Health Outcomes:Standards of Medical Care in Diabetes—2020
Diabetes Care (2019) Vol. 43, Iss. Supplement_1, pp. S48-S65
Open Access | Times Cited: 300
Diabetes Care (2019) Vol. 43, Iss. Supplement_1, pp. S48-S65
Open Access | Times Cited: 300
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S68-S96
Open Access | Times Cited: 275
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S68-S96
Open Access | Times Cited: 275
5. Facilitating Behavior Change and Well-being to Improve Health Outcomes:Standards of Medical Care in Diabetes—2021
Diabetes Care (2020) Vol. 44, Iss. Supplement_1, pp. S53-S72
Open Access | Times Cited: 268
Diabetes Care (2020) Vol. 44, Iss. Supplement_1, pp. S53-S72
Open Access | Times Cited: 268
4. Lifestyle Management
Diabetes Care (2016) Vol. 40, Iss. Supplement_1, pp. S33-S43
Open Access | Times Cited: 263
Diabetes Care (2016) Vol. 40, Iss. Supplement_1, pp. S33-S43
Open Access | Times Cited: 263
Current trends in drug metabolism and pharmacokinetics
Yuhua Li, Qiang Meng, Mengbi Yang, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 9, Iss. 6, pp. 1113-1144
Open Access | Times Cited: 253
Yuhua Li, Qiang Meng, Mengbi Yang, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 9, Iss. 6, pp. 1113-1144
Open Access | Times Cited: 253
5. Facilitating Behavior Change and Well-being to Improve Health Outcomes:Standards of Medical Care in Diabetes—2022
Diabetes Care (2021) Vol. 45, Iss. Supplement_1, pp. S60-S82
Closed Access | Times Cited: 229
Diabetes Care (2021) Vol. 45, Iss. Supplement_1, pp. S60-S82
Closed Access | Times Cited: 229
SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
Dustin M. Lee, Micah L. Battson, Dillon K. Jarrell, et al.
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 211
Dustin M. Lee, Micah L. Battson, Dillon K. Jarrell, et al.
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 211
The rise and fall of aspirin in the primary prevention of cardiovascular disease
Inbar Raber, Cian P. McCarthy, Muthiah Vaduganathan, et al.
The Lancet (2019) Vol. 393, Iss. 10186, pp. 2155-2167
Open Access | Times Cited: 168
Inbar Raber, Cian P. McCarthy, Muthiah Vaduganathan, et al.
The Lancet (2019) Vol. 393, Iss. 10186, pp. 2155-2167
Open Access | Times Cited: 168
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022
Tomonori Okamura, Kazuhisa Tsukamoto, Hidenori Arai, et al.
Journal of Atherosclerosis and Thrombosis (2023) Vol. 31, Iss. 6, pp. 641-853
Open Access | Times Cited: 136
Tomonori Okamura, Kazuhisa Tsukamoto, Hidenori Arai, et al.
Journal of Atherosclerosis and Thrombosis (2023) Vol. 31, Iss. 6, pp. 641-853
Open Access | Times Cited: 136
Associations of Type 2 Diabetes Onset Age With Cardiovascular Disease and Mortality: The Kailuan Study
Maoxiang Zhao, Lulu Song, Lan Sun, et al.
Diabetes Care (2021) Vol. 44, Iss. 6, pp. 1426-1432
Open Access | Times Cited: 112
Maoxiang Zhao, Lulu Song, Lan Sun, et al.
Diabetes Care (2021) Vol. 44, Iss. 6, pp. 1426-1432
Open Access | Times Cited: 112
Acute Kidney Injury in Patients on SGLT2 Inhibitors: A Propensity-Matched Analysis
Girish N. Nadkarni, Rocco Ferrandino, Alex R. Chang, et al.
Diabetes Care (2017) Vol. 40, Iss. 11, pp. 1479-1485
Open Access | Times Cited: 169
Girish N. Nadkarni, Rocco Ferrandino, Alex R. Chang, et al.
Diabetes Care (2017) Vol. 40, Iss. 11, pp. 1479-1485
Open Access | Times Cited: 169
Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials
Lauren L. O’Mahoney, Jamie Matu, Oliver J. Price, et al.
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 144
Lauren L. O’Mahoney, Jamie Matu, Oliver J. Price, et al.
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 144
Metabolic memory phenomenon in diabetes mellitus: Achieving and perspectives
Alexander Е. Berezin
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2016) Vol. 10, Iss. 2, pp. S176-S183
Closed Access | Times Cited: 136
Alexander Е. Berezin
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2016) Vol. 10, Iss. 2, pp. S176-S183
Closed Access | Times Cited: 136
Psychosocial Factors in Diabetes and Cardiovascular Risk
Ruth A. Hackett, Andrew Steptoe
Current Cardiology Reports (2016) Vol. 18, Iss. 10
Open Access | Times Cited: 135
Ruth A. Hackett, Andrew Steptoe
Current Cardiology Reports (2016) Vol. 18, Iss. 10
Open Access | Times Cited: 135
Adherence to a Vegetarian Diet and Diabetes Risk: A Systematic Review and Meta-Analysis of Observational Studies
Yujin Lee, Kyong Park
Nutrients (2017) Vol. 9, Iss. 6, pp. 603-603
Open Access | Times Cited: 129
Yujin Lee, Kyong Park
Nutrients (2017) Vol. 9, Iss. 6, pp. 603-603
Open Access | Times Cited: 129
Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia
Jean‐Charles Fruchart
Cardiovascular Diabetology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 127
Jean‐Charles Fruchart
Cardiovascular Diabetology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 127